Skip to main content
. 2022 Aug 3;16:973698. doi: 10.3389/fninf.2022.973698

TABLE 2.

Clinical characteristics of the enrolled patients.

Tumor type Gene status Gender
Age (Mean ± SD)
Female Male
NSCLC 30 30 57.82 ± 7.26
EGFR mutant 20 10 56.67 ± 7.20
EGFR wild-type 10 20 58.97 ± 7.13
Breast cancer 60 0 53.63 ± 10.53
HER2 positive 30 0 54.03 ± 10.82
HER2 negative 30 0 53.23 ± 10.21
Other 9 11 53.23 ± 10.21
Total 99 41 58.80 ± 13.45

NCSLC, Non-small-cell lung cancer.